SOCIAL MEDIA

© 2020 ApexQubit

DISCOVERY  OF  NEW  MEDICINES  Meets

AI  &  quantum  machine  learning

What  we  Do

We employ artificial intelligence and quantum machine learning for:

Optimization of the

CRISPR-Cas toolbox

Gene activation and 

repression mode, better ability to avoid an immune response, better gene-editing precision

Design of protein- based therapeutics

Generation of new small and mid-size molecules for specific protein-based diseases, their screening and prediction of binding affinity

Biomarkers

discovery

Development of less

invasive and smarter tests to diagnose patients earlier and to make prognostic assesments

FOr  whom

Our solutions empower:

Biotech
startups

New optimized gene-editing tools to cure undruggable single-gene diseases

Pharmaceutical
companies

Automation of the drug design process, common R&D projects

R&D

laboratories

Screening and optimization of potential drug candidates, biomarkers discovery

Artificial intelligence and quantum machine learning

together with new gene-editing technologies unlock an unseen before potential to our way to cure diseases that are staying undruggable for hundreds of years of an active research. And we are proud to be at the forefront of this revolution that is happining now in the medicine."

Denis Farnosov, Founder & CEO of ApexQubit

How  to  start  collaboration

Would like to discuss collaboration?